About Aliri

Aliri is committed to solving industry challenges by bringing innovative bioanalytical and spatial solutions to biotech and pharma, as the complexity of the drug development landscape continues to rise.

Our mission is to support our customers with bringing life-saving therapies to market with speed and agility. We are focused on providing pharma and biotech companies with bioanalytical lab, spatial bioanalysis, and spatial biology solutions that will bring unique, comprehensive data to enable strategic decision making for lead optimization and strengthen regulatory submissions.

Learn more about a vast range of bioanalytical lab, spatial bioanalysis, and spatial biology solutions that will help you advance your molecule from discovery through clinical development and NDA approval, while being backed by a network of technical experts and seasoned scientists.

Connect with us now

Learn more about a vast range of bioanalytical lab, spatial bioanalysis, and spatial biology solutions that will help you advance your molecule from discovery through clinical development and NDA approval, while being backed by a network of technical experts and seasoned scientists.

Connect with us now

Across our portfolio, we are committed to bringing strong customer service, scientific leadership, and regulatory excellence, which are all bound to our core values:

Action
Attentive
Aspire
Accountable

Our Leadership

Steve Lundy

Chief Executive Officer

Steve Lundy has 35 years of leadership experience in the laboratory diagnostics and medical device industries at organizations including Dianon Systems, GeneOhm Sciences, Biopix, MicroPhage, and most recently Bach Diagnostics, where he served as President. Throughout his career, he has held senior leadership positions at both private and public companies, raised millions of dollars in outside capital, led the commercialization of novel diagnostic products, achieved FDA approvals, and completed successful mergers. Steve’s top priorities include guiding Aliri’s strategic vision, driving market expansion, and creating sustained value for customers.

Kevin Jones

Chief Operating Officer

Kevin Jones brings over 25 years of leadership experience in operational excellence, global integration, laboratory operations, and strategic growth. He has had a long and distinguished career leading large multi-disciplinary teams on a global scale, including laboratories at Covance/LabCorp and IQVIA. Kevin is passionate about operational strategy, ensuring the continued delivery of exceptional service, operational excellence, and growth across all areas of the business.

Sylvain Chabanier

Chief Financial Officer

Following his graduation from ESCP Europe in 2007, Sylvain started an investment banker career in Mergers & Acquisitions department at Lazard. In 2014, Sylvain joined Sodexo global headquarters in France as an M&A Project Manager, covering various service lines within multiple geographies. In 2019, Sylvain was appointed Europe CFO for Entegra, a wholly-owned subsidiary of Sodexo specialized in Procurement services. Sylvain joined Aliri in May 2022 as Group CFO. Sylvain lives in Paris area. He is married and has two daughters.
Dawn Moore

Sr. VP of Business Development

With over 24 years of experience in Pharmaceutical R&D and Contract Research Business Development, Dawn has a proven track record of driving strategic growth while building strong teams and successful partnerships in the life sciences industry. She leads the company’s business development strategies, focusing on expanding partnerships, driving growth, and furthering Aliri’s mission to support our customers in bringing life-saving therapies to market with speed and agility.